CNBC “Fast Money” — Episode Summary
Episode Title: Different Reads On The Consumer… And Pharma’s Obesity Drug Price Negotiations
Date: November 5, 2025
Host: Melissa Lee
Panel: Guy Adami, Carter Worth, Dan Nathan, Steve Grasso
Special Guest: Stephen Yalof (CEO, Tanger Outlets); Evan David Segerman (Head of Healthcare Research, BMO)
Overview
This episode presents a highly dynamic debate on the current state of the American consumer, dissecting mixed signals coming from major earnings reports in retail, food, and services. The team also drills into high-profile developments in the pharma sector around obesity drug price negotiations and analyzes big after-hours moves from the tech sector. A major theme is the “bifurcation” or “K-shaped” nature of the current economy, highlighting diverging fortunes for different consumer segments and companies. The show features interviews with Tanger Outlets CEO Stephen Yalof and BMO’s Evan David Segerman to provide deeper industry perspective.
Key Discussion Points & Insights
1. A Tale of Two Consumers: The K-Shaped Economy
[00:58 - 08:45]
-
Mixed Corporate Signals:
- McDonald’s missed Wall Street earnings but saw higher same-store sales. However, low-end consumer foot traffic has declined by double digits, a trend echoed by Chipotle and Kava.
- Quote: “The people that are doing well ... are trading down but are still a bit have the ability to spend, and then on the lower end, people are strapped.” (Guy Adami, 02:41)
- DoorDash and Elf Beauty show pressure among lower-end consumers, while Shopify and Uber report strong customer demand.
- Live Nation (Ticketmaster) fell sharply; experiences and concerts were the "revenge spending" story but are seen unwinding now.
- Discounters and dollar stores report struggles; “the middle” is especially squeezed.
- McDonald’s missed Wall Street earnings but saw higher same-store sales. However, low-end consumer foot traffic has declined by double digits, a trend echoed by Chipotle and Kava.
-
Consumer Behavioral Shifts:
- Trading down (affluent shopping at Walmart/Costco).
- Stretching groceries, avoiding restaurants, increased at-home consumption.
- “If you're trapped in your home, you can't get the money out of your home, that's a huge thing. People wind up being house rich, cash poor.” (Steve Grasso, 04:51)
-
Labor Market & Affluent Consumers:
- Layoffs increasingly impacting corporate, white-collar roles, threatening what’s been the resilient upper-end spending segment.
-
Market Sectors and Stock Picks:
- Mixed performance among luxury brands. Select high-end brands like Ralph Lauren/Williams Sonoma outperform, while others lag.
- Walmart praised for using AI to boost margins (Guy Adami, 08:23)
- "I believe Walmart is winning in terms of utilizing AI and improving margins. So Walmart specifically, yes, I think you can pay up for the stock."
2. Equity Sector Breakdown and Insights
[09:10 - 09:52]
- Costco membership “sticky” (over 90% renewal) and product mix enables efficiency and tariff avoidance.
- Consumer discretionary sector ex-Amazon/Tesla: equal-weighted index down sharply, true measure of sector’s weakness.
- “The equal-weighted consumer discretionary sector is the true message of that area of the market.” (Carter Worth, 09:23)
3. Expert Interview: Tanger CEO Stephen Yalof on Real Retail Traffic
[09:52 - 17:40]
-
Retail Leasing & Foot Traffic:
- Reports record leasing volume and optimism for holiday traffic, based on strong store stocking and staffing metrics.
- Outlet channel value propositions, branding, and “sale every day” messaging are highly resonant.
- “Being on sale every day is a really powerful message to the consumer, especially now.” (Stephen Yalof, 11:13)
- Shift: customer demographics now trend younger; brands competing by pricing below inflation to keep millennials/Gen Z shopping.
- "The brand pricing is actually with the markdown... below the cost of inflation." (Yalof, 11:34)
-
Operational Adaptations:
- Adoption of customer analytics and targeted merchandising.
- Key brands (Lululemon, Sephora) act as “anchors” to drive both consumer and other retailer interest.
-
Nike & Footwear Segment:
- Even as full-price Nike faces challenges, brand remains robust at value-oriented outlet locations due to aspirational demand.
- "Our consumer is not coming in looking for commodity. They want Nikes, and they want Nikes at the best price." (Yalof, 14:12)
- Even as full-price Nike faces challenges, brand remains robust at value-oriented outlet locations due to aspirational demand.
-
Experiential Partnerships:
- Tanger’s partnership with Unrivaled Sports to draw foot traffic from youth sports events.
- “It is incumbent on us as operator to drive traffic...they host these travel team events and, because they're so proximate to our shopping centers, our partnership allows us to share their experiences and also be on the itinerary.” (Yalof, 15:03)
- Tanger’s partnership with Unrivaled Sports to draw foot traffic from youth sports events.
-
Panel Reaction:
- Tanger praised as a “relative strength” operator, outperforming during downturns (Carter Worth, 17:40).
4. After-Hours Earnings: Snap, Qualcomm, Roku, CAT, and More
[17:52 - 42:00]
Snap (SNAP) Surges on Earnings Beat
[17:52 - 20:13]
- Revenue, user growth, new $500M buyback, and Perplexity AI chatbot deal push shares up 26%.
- "For a company this size, a $500 million stock buyback is not insignificant." (Guy Adami, 19:49)
- Panel cautious about chasing; recommend three-day rule.
Qualcomm (QCOM)
[28:01 - 29:54]
- Beats on revenue and earnings, but stock gives up gains after hours.
- Seen as undervalued and a buy on weakness for long-term investors.
- “If you want to put in a value in this space, I think Qualcomm still makes sense.” (Guy Adami, 28:23)
Others:
- Robinhood and ARM Holdings: Beat expectations.
- Lyft: Slight miss.
- Doordash & ELF Beauty: Missed expectations, cited choppy consumer landscape.
- Trex (decking): Major drop on weak repair/remodel and home improvement spending.
5. Supreme Court Hears Tariff Challenge
[22:11 - 27:01]
- Hearing on legality of Trump-era tariffs; up to $90B potentially at stake for businesses.
- “Even conservative justices [are] expressing skepticism...because that law does not mention tariffs, and tariff power belongs to Congress.” (Eamon Jabers, 23:07)
- Retailers (Macy’s, Target) rose on hopes that paying customers back for tariffs could lift the sector, but panel skeptical about long-term impact.
- “Any bounce in Target to me is a selling opportunity. I think they still are under considerable pressure.” (Guy Adami, 25:04)
- Discussion on whether a broad government payout or legal settlement would meaningfully change the macro environment.
6. Pharma Focus: Obesity Drug Price Negotiations and M&A Battle
[31:50 - 37:24]
-
Novo Nordisk vs. Pfizer for Medcera:
- Medcera is highly sought due to its pipeline in obesity treatment, a $130B+ market.
- “A de-risked obesity asset is hot, and it's pretty clear this is something Pfizer and Novo want.” (Evan David Segerman, 34:17)
- Pfizer could quickly close a deal thanks to FTC clearance; if Novo wins, FTC review could take years, possibly allowing Lilly to extend its lead.
- Panel notes that for Novo, Medcera helps fill portfolio gaps, while for Pfizer, it's entry into a blockbuster market.
- Medcera is highly sought due to its pipeline in obesity treatment, a $130B+ market.
-
Obesity Drug Pricing and Medicare/Medicaid Access:
- Anticipated deal: lower starting dose pricing in exchange for Medicare/Medicaid coverage (previously only Type 2 diabetes covered).
- Significant for unlocking new patient populations.
- “That's been kind of the missing piece when it comes to the obesity market getting real Medicare coverage.” (Segerman, 35:12)
- Net effect: Positive for Eli Lilly (raising guidance, new drugs in pipeline); Novo lagging due to repeated guidance cuts.
7. Stock Pitches & Chartmaster Segment: Roku vs Caterpillar
[38:46 - 42:34]
- Roku:
- After losing 90%+ from its highs, now basing, chart suggests upside—seen as a classic “bearish to bullish reversal.”
- “This action to my eyes suggests higher prices.” (Carter Worth, 38:46)
- After losing 90%+ from its highs, now basing, chart suggests upside—seen as a classic “bearish to bullish reversal.”
- Caterpillar:
- Extended well above historical trend; some panelists see AI exposure as a re-rating opportunity, others skeptical.
- “AI trade with CAT sounds very 2000 to me ... I just don’t think it’s a tractor company.” (Dan Nathan, 42:00)
- Carter Worth: “Analysts’ consensus price target is $571; it closed at $569, so I guess all those smart people don’t think much of it.”
- Panel split: Steve Grasso and Guy Adami prefer the upside in Roku, see Caterpillar as mature but not overvalued.
- Extended well above historical trend; some panelists see AI exposure as a re-rating opportunity, others skeptical.
8. Tech & AI: Apple and Google Deal
[42:58 - 44:55]
- Apple will pay Google ~$1 billion/year to use its Gemini AI models in Siri, a sign that Apple is well behind in foundational AI models.
- “They've never been the great innovator, they've been the great replicator. I think that’s a positive for Apple going forward.” (Steve Grasso, 44:45)
- Suggests Apple content to iterate rather than lead in AI arms race; may ultimately benefit from a fast-follower strategy.
Notable Quotes & Moments
- “We have a bifurcated market—as is the case...if you're in the dollar stores, that's been a rough slog over the last couple of years.” (Guy Adami, 02:41)
- “Delta is ... selling more first class tickets than coach for the first time ever.” (Steve Grasso, 04:51)
- “Bifurcation is a word that's in the English language for a long time. We have a bifurcated market as is the case." (Carter Worth, 05:53)
- “If the tariffs are reversed, that's $90B going out of Treasury...but who gets the largest checks? For which of them would that check be big enough to be material to their stock price?" (Eamon Jabers, 23:07)
- "A de-risked obesity asset is hot...I expect the Pfizer bid to potentially best Novo Nordisk." (Evan David Segerman, 34:17)
- "Momentum is not just up, it's down. And so it has to be respected...this is just an established downtrend, stay away from [Novo]." (Carter Worth, 37:05)
- "AI trade with CAT sounds very 2000 to me ... I just don’t think it’s a tractor company.” (Dan Nathan, 42:00)
Timestamps for Important Segments
- The Consumer/Bifurcation Theme: 00:58 – 08:45
- Panel Stock Picks (Walmart, Costco): 08:15 – 09:10
- Tanger CEO, Retail Realities: 09:52 – 17:40
- Snap Earnings News/Panel Take: 17:52 – 20:13
- Qualcomm and Semiconductor Insights: 28:01 – 29:54
- Supreme Court and Tariffs: 22:11 – 27:01
- Obesity Drug Pharma M&A & Pricing: 31:50 – 37:24
- Roku vs CAT Chartmaster Segment: 38:46 – 42:34
- Apple/Google AI Deal Analysis: 42:58 – 44:55
Final Trades
[45:13]
- Steve Grasso: Delta — “Positive momentum, positive earnings revisions.”
- Carter Worth: Roku — “On the mend, making the turn.”
- Dan Nathan: Apple — “I'd be a trimmer.”
- Guy Adami: Structured Therapeutics — M&A play.
Summary Tone
The conversation is rapid, sharp, notably skeptical of consensus narratives, and peppered with sector insights and tactical trading commentary. There’s healthy disagreement about valuation and strategy, with the “original Fast Money” blend of banter and actionable market perspective.
